An Efficient and Footprint-Free Protocol for the Transdifferentiation of Hepatocytes Into Insulin-Producing Cells With IVT mRNAs
暂无分享,去创建一个
L. Dai | Ya-hong Yuan | Junming Tang | Yan Ding | Mengjie Yang | Wenhui Zhou | Dongsheng Li | Xiaoli Wang | Shinan Ma | Xingrong Guo
[1] E. Tai,et al. New insights into human beta cell biology using human pluripotent stem cells. , 2019, Seminars in cell & developmental biology.
[2] S. Shalitin,et al. Type 1 diabetes mellitus management in young children: implementation of current technologies , 2019, Pediatric Research.
[3] J. Ciriza,et al. Review of Advanced Hydrogel-Based Cell Encapsulation Systems for Insulin Delivery in Type 1 Diabetes Mellitus , 2019, Pharmaceutics.
[4] S. Ferber,et al. Liver to Pancreas Transdifferentiation , 2019, Current Diabetes Reports.
[5] M. Ko,et al. Establishment of a rapid and footprint-free protocol for differentiation of human embryonic stem cells into pancreatic endocrine cells with synthetic mRNAs encoding transcription factors , 2018, Stem Cell Research & Therapy.
[6] E. Pone,et al. Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes , 2018, Front. Immunol..
[7] Y. Ikeda,et al. PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration , 2017, Stem Cell Research & Therapy.
[8] F. Avolio,et al. β-Cell Replacement Strategies: The Increasing Need for a “β-Cell Dogma” , 2017, Front. Genet..
[9] Yong Wang,et al. Islet Microencapsulation: Strategies and Clinical Status in Diabetes , 2017, Current Diabetes Reports.
[10] Dongjun Liu,et al. Effect of Wnt Signaling on the Differentiation of Islet β-Cells from Adipose-Derived Stem Cells , 2017, BioMed research international.
[11] E. Bonifacio,et al. Stepwise reprogramming of liver cells to a pancreas progenitor state by the transcriptional regulator Tgif2 , 2017, Nature Communications.
[12] JG Allickson. Emerging Translation of Regenerative Therapies , 2017, Clinical pharmacology and therapeutics.
[13] S. Ferber,et al. Reprogramming of liver cells into insulin-producing cells. , 2015, Best practice & research. Clinical endocrinology & metabolism.
[14] J. Rosenecker,et al. Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration , 2015, PloS one.
[15] D. S. Li,et al. Gene Manipulation of Human Embryonic Stem Cells by In Vitro-Synthesized mRNA for Gene Therapy. , 2015, Current gene therapy.
[16] A. Wrońska,et al. In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells. , 2015, Folia histochemica et cytobiologica.
[17] Bo Kara,et al. The translation of cell-based therapies: clinical landscape and manufacturing challenges. , 2015, Regenerative medicine.
[18] Satoru Takahashi,et al. Generation of Insulin-Producing Cells from the Mouse Liver Using β Cell-Related Gene Transfer Including Mafa and Mafb , 2014, PloS one.
[19] Dong Sheng Li,et al. Reprogramming human umbilical cord mesenchymal stromal cells to islet-like cells with the use of in vitro-synthesized pancreatic-duodenal homebox 1 messenger RNA. , 2014, Cytotherapy.
[20] Irit Meivar-Levy,et al. The Temporal and Hierarchical Control of Transcription Factors-Induced Liver to Pancreas Transdifferentiation , 2014, PloS one.
[21] H. Kaneto,et al. Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells. , 2009, Current medicinal chemistry.
[22] A. Brivanlou,et al. The Gata5 target, TGIF2, defines the pancreatic region by modulating BMP signals within the endoderm , 2008, Development.
[23] M. Hamid,et al. COMPARISON OF THE SECRETORY PROPERTIES OF FOUR INSULIN-SECRETING CELL LINES , 2002, Endocrine research.
[24] M. Atkinson,et al. Genetically reprogrammed, liver-derived insulin-producing cells are glucose-responsive, but susceptible to autoimmune destruction in settings of murine model of type 1 diabetes. , 2013, American journal of translational research.